What can we do to optimize mitochondrial transplantation therapy for myocardial ischemia-reperfusion injury?

• Published in: Mitochondrion 2023-09, Vol.72, p.72-83
• Main Authors: Liu, Qian, Liu, Meng, Yang, Tianshu, Wang, Xinting, Cheng, Peipei, Zhou, Hua
• Format: Article
• Language: English
• ISSN: 1567-7249; 1872-8278
• DOI: 10.1016/j.mito.2023.08.001

Mitochondrial transplantation is a promising solution for the heart following ischemia-reperfusion injury due to its capacity to replace damaged mitochondria and restore cardiac function. However, many barriers (such as inadequate mitochondrial internalization, poor survival of transplanted mitochondria, few mitochondria colocalized with cardiac cells) compromise the replacement of injured mitochondria with transplanted mitochondria. Therefore, it is necessary to optimize mitochondrial transplantation therapy to improve clinical effectiveness. By analogy, myocardial ischemia-reperfusion injury is like a withered flower, it needs to absorb enough nutrients to recover and bloom. In this review, we present a comprehensive overview of "nutrients" (source of exogenous mitochondria and different techniques for mitochondrial isolation), "absorption" (mitochondrial transplantation approaches, mitochondrial transplantation dose and internalization mechanism), and "flowering" (the mechanism of mitochondrial transplantation in cardioprotection) for myocardial ischemia-reperfusion injury.